Stephen Silberstein, MD

Stephen Silberstein, MD

Contact Dr. Silberstein

900 Walnut Street
Second Floor
Philadelphia, PA 19107

(215) 955-2243
(215) 955-2060 fax

Most Recent Peer-reviewed Publications

  1. Preventive Treatment for Episodic Migraine
  2. Novel Medications for the Treatment of Migraine
  3. Remote Electrical Neuromodulation (REN) Relieves Acute Migraine: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial
  4. Pathophysiology, prevention, and treatment of medication overuse headache
  5. Fremanezumab for the preventive treatment of migraine
  6. Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trial
  7. Targeting CGRP for the Prevention of Migraine and Cluster Headache: A Narrative Review
  8. Vestibular Neuroscience for the Headache Specialist
  9. Early onset of effect of onabotulinumtoxinA for chronic migraine treatment: Analysis of PREEMPT data
  10. Adherence to the 2008 IHS guidelines for controlled trials of drugs for the preventive treatment of chronic migraine in adults
  11. Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A meta-analysis
  12. Galcanezumab in episodic migraine: Subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)
  13. The endocannabinoid system in migraine: From bench to pharmacy and back
  14. Safety and Tolerability of Fremanezumab for the Prevention of Migraine: A Pooled Analysis of Phases 2b and 3 Clinical Trials
  15. Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study
  16. Rationale for electrical parameter determination in external trigeminal nerve stimulation (eTNS) for migraine: A narrative review
  17. Calcitonin Gene-Related Peptide Antagonists in the Treatment of Episodic Migraine
  18. Guidelines of the International Headache Society for controlled trials of acute treatment of migraine attacks in adults: Fourth edition
  19. Current Status of Antiepileptic Drugs as Preventive Migraine Therapy
  20. Invited Commentary on Preventive Anti-Migraine Therapy (PAMT)